Evidence map›Paper›PMID 34999719›Full record

ReviewJournal of human hypertension2022

Relationship between serum 25-hydroxyvitamin D and target organ damage in children with essential hypertension.

Yang Liu, Lin Shi, Yao Lin, Mingming Zhang, Fangfang Chen, Aijie Li, Yanyan Liu

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of human hypertension, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Latest Knowledge on the Role of Vitamin D in Hypertension.International journal of molecular sciences · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yang LiuDepartment of Cardiology, Children's Hospital Affiliated to Capital Institute of Pediatrics, 100020, Beijing, China.ORCID 0000-0002-5923-7411
Lin ShiDepartment of Cardiology, Children's Hospital Affiliated to Capital Institute of Pediatrics, 100020, Beijing, China. shilin9789@126.com.ORCID 0000-0001-7578-7440
Yao LinDepartment of Cardiology, Children's Hospital Affiliated to Capital Institute of Pediatrics, 100020, Beijing, China.
Mingming ZhangDepartment of Cardiology, Children's Hospital Affiliated to Capital Institute of Pediatrics, 100020, Beijing, China.
Fangfang ChenDepartment of Epidemiology, Capital Institute of Pediatrics, 100020, Beijing, China.
Aijie LiDepartment of Cardiology, Children's Hospital Affiliated to Capital Institute of Pediatrics, 100020, Beijing, China.
Yanyan LiuDepartment of Cardiology, Children's Hospital Affiliated to Capital Institute of Pediatrics, 100020, Beijing, China.
Capital Institute of Pediatrics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Researchers have shown that 25-hydroxyvitamin D (25[OH] D), a kind of active vitamin D in the human body, plays a role in cardiovascular disease (CVD). Low serum 25(OH) D levels have been found to be associated with elevated blood pressure (BP) in adults. However, measurement of 25(OH) D in hypertensive children has not been documented. The aim of this study was to investigate the relationship between 25(OH) D and target organ damage (TOD) in children with essential hypertension. We recruited a total of 346 children with essential hypertension and analyzed the correlation between serum 25(OH) D and TOD. Serum 25(OH) D concentration was significantly lower in the TOD than in the no-TOD group (t = 2.416, P = 0.016), as well as significantly lower in the two-organ damage than in the single-organ damage group (t = 3.140, P = 0.002). Pearson's correlation coefficient (PCC) indicated that serum 25(OH) D levels were negatively correlated with left ventricular mass index (LVMI; r = -0.110, P = 0.041) and albuminuria (r = -0.120, P = 0.026). Linear- regression analysis showed that 25(OH) D was a risk factor for left ventricular hypertrophy (LVH; β ± s.e. =-0.074 ± 0.036; 95% confidence interval [CI], - 0.145 to -0.003; P < 0.001) and renal damage (β ± s.e.= -0.018 ± 0.008; 95% CI, - 0.035 to -0.002; P = 0.004). In total, our data revealed that serum 25(OH) D was independently associated with hypertensive cardiac and renal damage, meaning that it was a risk factor for LVH and albuminuria in childhood hypertension.

Indexed as

AlbuminuriaHypertensionAdultBlood PressureChildEssential HypertensionHumansHypertrophy, Left VentricularVitamin D25-hydroxyvitamin DVitamin D

Identifiers

PMID34999719
PMCPMC9287164
OpenAlexW4206563955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.